| ACL | Anterior Cruciate Ligament |
| PRP | Platelet-Rich Plasma |
| PRF | Platelet-Rich Fibrin |
| BMAC | Bone Marrow Aspirate Concentrate |
| MSC | Mesenchymal Stem Cell |
| EVs | Extracellular Vesicles |
| ADSCs | Adipose-Derived Stem Cells |
| ADRCs | Adipose-Derived Regenerative Cells |
| MRI | Magnetic Resonance Imaging |
| US | Ultrasound |
| UTE-T2* | Ultrashort Echo Time T2-star (advanced MRI mapping sequence) |
| T2* | T2-star relaxation time (MRI parameter sensitive to tissue microstructure and field inhomogeneity) |
| CRISPR-Cas9 | Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated protein 9 (gene editing tool) |
| RCT | Randomized Controlled Trial |
| IKDC | International Knee Documentation Committee score |
| KOOS | Knee Injury and Osteoarthritis Outcome Score |
| Lysholm | Lysholm Knee Scoring Scale |
| PROs | Patient Reported Outcomes |
| DBM | Demineralized Bone Matrix |
| LP-PRP | Leukocyte-Poor Platelet Rich Plasma |
| LR-PRP | Leukocyte-Rich Platelet Rich Plasma |
| BLA | Biologics License Application |
| FDA | U.S. Food and Drug Administration |
| HCT/P | Human Cells, Tissues, and Cellular and Tissue-Based Products |
| VEGF | Vascular Endothelial Growth Factor |
| PDGF | Platelet-Derived Growth Factor |
| TGF-β | Transforming Growth Factor Beta |
| IL-1β | Interleukin-1 Beta |
| TNF-α | Tumor Necrosis Factor Alpha |
| MMPs | Matrix Metalloproteinases |
| TIMP-1 | Tissue Inhibitor of Metalloproteinase-1 |